sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity

$735,994

Sixto Manuel Leal · University Of Alabama At Birmingham · R01 · FY2024 · AI

Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)

$735,747

Usha Sethuraman · Central Michigan University · R33 · FY2023 · HD

MRI: Acquisition of an integrated Zeiss 980 microscope with Airyscan 2 and FCS to advance multidisciplinary research, inclusive teaching, and outreach at Amherst College

$735,648

Sally A Kim · Amherst College · · FY2021 · BIO

Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)

$735,449

Usha Sethuraman · Central Michigan University · R61 · FY2021 · HD

Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines

$735,446

Robert Brosh · National Institute On Aging · ZIA · FY2021 · AG

Deep sequencing SARS-CoV-2 samples from New Mexico to interrogate immunological selection on genetic variants

$734,660

Shelley Lusetti · New Mexico State University Las Cruces · P20 · FY2021 · GM

Computational design and development of small protein inhibitors

$734,649

Eva-Maria Strauch · Washington University · R01 · FY2025 · AI

RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES--TASK AREA A, ADMINISTRATIVE SUPPORT

$733,923

Mark Marino · Venturewell · N02 · FY2021 · HL

Mechanistic modeling of the innate immune responses of the human lung to understand the inter-individual heterogeneity of COVID-19 pneumonia

$733,796

Borna Mehrad · University Of Florida · R01 · FY2025 · HL

Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential

$733,730

Kyeong-Ok Chang · Kansas State University · R01 · FY2025 · AI

Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans

$733,725

Ivan Zanoni · Boston Children'S Hospital · R01 · FY2025 · AI

Deep Learning and Subtyping of Post-COVID-19 Lung Progression Phenotypes

$733,586

Ching-Long Lin · University Of Iowa · R01 · FY2025 · HL

Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics development

$732,990

Priyamvada Acharya · Duke University · R01 · FY2020 · AI

BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTS

$732,923

Leopoldo Nicolas Segal · New York University School Of Medicine · R33 · FY2025 · GM

Small Molecule Protease Inhibitors against MERS-CoV

$732,873

Kyeong-Ok Chang · Kansas State University · R01 · FY2020 · AI

The COVID-19 and Cancer Consortium (CCC19) Registry

$732,687

Jeremy Lyle Warner · Rhode Island Hospital · U01 · FY2024 · CA

SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects

$732,439

Pandurangan Vijayanand · La Jolla Institute For Immunology · U01 · FY2022 · CA

Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2

$732,439

Susan C. Baker · Loyola University Chicago · R01 · FY2025 · AI

Elucidating the immunology of autoantibody formation and function in COVID-19

$732,313

Angela J Rogers · Stanford University · R01 · FY2024 · AI

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity

Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)

MRI: Acquisition of an integrated Zeiss 980 microscope with Airyscan 2 and FCS to advance multidisciplinary research, inclusive teaching, and outreach at Amherst College

Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)

Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines

Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2

Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2

Molecular Targets Modulating Neuro COVID Sequelae Linked to Tauopathy

Small Molecule Protease Inhibitors against MERS-CoV

COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS)

SARS-CoV-2 Virology Core

Deep sequencing SARS-CoV-2 samples from New Mexico to interrogate immunological selection on genetic variants

Computational design and development of small protein inhibitors

RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES--TASK AREA A, ADMINISTRATIVE SUPPORT

Mechanistic modeling of the innate immune responses of the human lung to understand the inter-individual heterogeneity of COVID-19 pneumonia

Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential

Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans

Deep Learning and Subtyping of Post-COVID-19 Lung Progression Phenotypes

Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics development

BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTS

Small Molecule Protease Inhibitors against MERS-CoV

The COVID-19 and Cancer Consortium (CCC19) Registry

SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects

Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2

Elucidating the immunology of autoantibody formation and function in COVID-19